Dashboard
Manage Tickers

BCYCBICYCLE THERAPEUTICS plc

Nasdaq bicycletherapeutics.com


$ 26.35 $ 5.82 (28.33 %)    

Monday, 09-Sep-2024 15:59:45 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 26.36
$ 21.03
$ 26.31 x 200
-- x --
$ 21.03 - $ 26.77
$ 12.54 - $ 27.24
874,097
na
1.82B
$ 1.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-20-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-28-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 03-11-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 03-10-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

needham-reiterates-buy-on-bicycle-therapeutics-maintains-38-price-target
Needham Reiterates Buy on Bicycle Therapeu...
09/09/2024 17:23:53

Needham analyst Ami Fadia reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $38 price target.

cantor-fitzgerald-reiterates-overweight-on-bicycle-therapeutics
Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 12:55:43

Cantor Fitzgerald analyst Li Watsek reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Overweight.

bicycle-therapeutics-lead-cancer-candidates-has-high-opportunity-analyst-initiates-with-bullish-tone
Bicycle Therapeutics' Lead Cancer Candidat...
09/06/2024 17:37:16

RBC Capital initiates coverage on Bicycle Therapeutics, highlighting Zelenectide's potential in oncology with improved safe...

in-depth-examination-of-5-analyst-recommendations-for-bicycle-therapeutics
In-Depth Examination Of 5 Analyst Recommen...
09/06/2024 12:01:06

rbc-capital-initiates-coverage-on-bicycle-therapeutics-with-outperform-rating-announces-price-target-of-35
RBC Capital Initiates Coverage On Bicycle ...
09/06/2024 09:56:24

RBC Capital analyst Gregory Renza initiates coverage on Bicycle Therapeutics (NASDAQ:BCYC) with a Outperform rating and anno...

the-latest-analyst-ratings-for-bicycle-therapeutics
The Latest Analyst Ratings For Bicycle The...
08/07/2024 21:00:17

hc-wainwright--co-reiterates-buy-on-bicycle-therapeutics-maintains-55-price-target
HC Wainwright & Co. Reiterates Buy on Bicy...
08/07/2024 20:17:14

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintain...

oppenheimer-maintains-outperform-on-bicycle-therapeutics-maintains-48-price-target
Oppenheimer Maintains Outperform on Bicycl...
08/07/2024 18:01:08

Oppenheimer analyst Jay Olson maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Outperform and maintains $48 price target.

5needham-reiterates-buy-on-bicycle-therapeutics-maintains-38-price-target
5Needham Reiterates Buy on Bicycle Therape...
08/07/2024 10:39:02

Needham analyst Ami Fadia reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $38 price target.

b-riley-securities-downgrades-bicycle-therapeutics-to-neutral-lowers-price-target-to-28
B. Riley Securities Downgrades Bicycle The...
08/07/2024 09:55:23

B. Riley Securities analyst Kalpit Patel downgrades Bicycle Therapeutics (NASDAQ:BCYC) from Buy to Neutral and lowers the pr...

bicycle-therapeutics-q2-2024-gaap-eps-077-beats-122-estimate-sales-9361m-beat-6071m-estimate
Bicycle Therapeutics Q2 2024 GAAP EPS $(0....
08/06/2024 12:00:30

bicycle-therapeutics-filed-a-prospectus-supplement-with-respect-to-resale-by-selling-securityholders-up-to-377m-ordinary-shares-with-each-ordinary-share-represented-by-1-american-depositary-share
Bicycle Therapeutics Filed A Prospectus Su...
06/18/2024 20:23:42

- SEC Filing

dow-dips-over-550-points-bjs-wholesale-club-earnings-beat-views
Dow Dips Over 550 Points; BJ's Wholesale C...
05/23/2024 18:40:33

gold-falls-sharply-us-composite-pmi-surges-in-may
Gold Falls Sharply; US Composite PMI Surge...
05/23/2024 16:01:36

elf-beauty-posts-upbeat-earnings-joins-nvidia-liveramp-holdings-borr-drilling-and-other-big-stocks-moving-higher-on-thursday
e.l.f. Beauty Posts Upbeat Earnings, Joins...
05/23/2024 14:26:28

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/23/2024 12:06:48

bicycle-therapeutics-reports-555m-private-placement-equity-financing-says-financing-includes-participation-from-new-and-existing-investors
Bicycle Therapeutics Reports $555M Private...
05/23/2024 11:16:44

The company has entered into a securities purchase agreement with certain existing and new accredited investors to issue and se...

hc-wainwright--co-reiterates-buy-on-bicycle-therapeutics-maintains-55-price-target
HC Wainwright & Co. Reiterates Buy on Bicy...
05/03/2024 19:20:12

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintain...

bicycle-therapeutics-cash-and-cash-equivalents-of-457m-as-of-march-31-2024-expected-to-provide-financial-runway-into-2026
Bicycle Therapeutics' Cash And Cash Equiva...
05/02/2024 11:53:41

bicycle-therapeutics-q1-2024-gaap-eps-062-beats-131-estimate-sales-19530m-beat-6029m-estimate
Bicycle Therapeutics Q1 2024 GAAP EPS $(0....
05/02/2024 11:53:23

Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION